BiotechTubeBiotechTube
Home/Photocure/Dan Schneider
DS

Dan Schneider

President and Chief Executive Officer (CEO)

Photocure

Therapeutic Areas

Urologic OncologyGynecologic Oncology

Photocure Pipeline

DrugIndicationPhase
Hexvix/Cysview (hexaminolevulinate)Diagnosis of Non-Muscle-Invasive Bladder Cancer (NMIBC)Approved
CEVIRA (APL-1702)Cervical Precancerous Lesions (HSIL)Phase 3 / Approved in China
AI for Blue Light CystoscopyEnhanced diagnosis of Bladder CancerDevelopment

Leadership Team at Photocure

JB
Jonathan Belsey
MB BS (quoted as study author, likely senior medical/health economics role)
View full Photocure profile